XML 79 R20.htm IDEA: XBRL DOCUMENT
v3.20.1

STOCK OPTIONS | 12 Months Ended
--- | ---
Dec. 31, 2019
STOCK OPTIONS |
STOCK OPTIONS | 14. STOCK OPTIONS Stock options Options for the purchase of 3,649,508 shares of Common Stock have been issued under the 2008 Stock Option Plan. Options for the purchase of 639,300 shares under the 2008 Stock Option Plan were outstanding as of December 31, 2019. No shares are available for future issuance under the 2008 Stock Option Plan which expired July 25, 2018. The Compensation and Benefits Committee administered the Company’s stock option plan prior to its termination. Director, officer and employee options A summary of Director, officer, and employee options granted and outstanding under the 2008 Stock Option Plan is presented below:
|  | Years Ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  |  | Weighted |  |  |  | Weighted |  |  |  | Weighted
|  |  |  | Average |  |  |  | Average |  |  |  | Average
|  |  |  | Exercise |  |  |  | Exercise |  |  |  | Exercise
|  | Shares |  | Price |  | Shares |  | Price |  | Shares |  | Price
Outstanding at beginning of period |  | 1,300,303 |  | $ | 1.57 |  | 1,805,519 |  | $ | 1.51 |  | 1,817,919 |  | $ | 1.52
Granted |  | — |  | $ | — |  | — |  | $ | — |  | — |  | $ | —
Exercised |  | — |  | $ | — |  | — |  | $ | — |  | — |  | $ | —
Forfeited |  | (661,003) |  | $ | (1.05) |  | (505,216) |  | $ | (1.36) |  | (12,400) |  | $ | (2.75)
Outstanding at end of period |  | 639,300 |  | $ | 2.12 |  | 1,300,303 |  | $ | 1.57 |  | 1,805,519 |  | $ | 1.51
Exercisable at end of period |  | 639,300 |  | $ | 2.12 |  | 1,300,303 |  | $ | 1.57 |  | 1,803,119 |  | $ | 1.51
No options were issued in 2019, 2018 or 2017 to employees or non-employee directors. The following table summarizes information about Director, officer, and employee options outstanding under the stock option plan at December 31, 2019:
|  |  |  | Weighted Average |  |
Exercise Prices |  | Shares Outstanding |  | Remaining Contractual Life |  | Shares Exercisable
$ | 1.46 |  | 50,000 |  | 3.37 |  | 50,000
$ | 1.05 |  | 200,000 |  | 6.99 |  | 200,000
$ | 2.75 |  | 389,300 |  | 6.70 |  | 389,300
Non-employee options A summary of options outstanding and held by non-employees is as follows:
|  | Years Ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  |  |  | Weighted |  |  |  | Weighted |  |  |  | Weighted
|  |  |  | Average |  |  |  | Average |  |  |  | Average
|  | Shares |  | Exercise Price |  | Shares |  | Exercise Price |  | Shares |  | Exercise Price
Outstanding at beginning of period |  | 57,500 |  | $ | 0.81 |  | 57,500 |  | $ | 0.81 |  | 57,500 |  | $ | 0.81
Granted |  | - |  | $ | - |  | — |  | $ | — |  | — |  | $ | —
Exercised |  | - |  | $ | - |  | — |  | $ | — |  | — |  | $ | —
Forfeited |  | (57,500) |  | $ | (0.81) |  | — |  | $ | — |  | — |  | $ | —
Outstanding at end of period |  | - |  | $ | - |  | 57,500 |  | $ | 0.81 |  | 57,500 |  | $ | 0.81
Exercisable at end of period |  | - |  | $ | - |  | 57,500 |  | $ | 0.81 |  | 57,500 |  | $ | 0.81
In 2017, the Company recognized stock-based compensation expense of $672 thousand. The Company recorded no stock-based compensation expense in 2018 or 2019. At December 31, 2019, there were 250,000 stock options with exercise prices lower than the closing market. The intrinsic value of these options at December 31, 2019 was $92,000. Options Pricing Models – Assumptions The expected life is based on the Company’s historical experience with option exercise trends. The assumptions for expected volatility are based on a calculation of volatility over the five-years preceding the grant date. Risk-free interest rates are set using grant-date U.S. Treasury yield curves. In its calculations, the Company assumed no dividends. The Company elected a policy to account for forfeitures as they occur, rather than on an estimated basis.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration